3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oropharyngeal Neoplasms
4
Head and Neck Neoplasms
3
Lung Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Rectal Malignant Neoplasms
1
Radiation Injuries
1
Postoperative Complications
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Low Anterior Resection Syndrome
1
Laryngeal Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
HPV-Related Squamous Cell Carcinoma
1
Fatigue
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Gemcitabine
29
pembrolizumab
21
Cisplatin
20
Specimen Handling
17
Magnetic Resonance Spectroscopy
17
enfortumab vedotin
10
Mitomycin
10
durvalumab
9
Cystoscopy
9
avelumab
8
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
6
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Docetaxel
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
Immunoglobulin G
4
Disulfides
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Chemoradiotherapy
×
90 days
×
Clear all
No trials found.